Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 2:33 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2593–2616 of 2,764 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: High Activity Clear all

Conditions: Prostate Cancer
Interventions: Nilutamide, Dasatinib; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 3
States / cities: Durham, North Carolina • Portland, Oregon • Seattle, Washington

Conditions: Obesity, Obesity, Childhood, Weight Gain, Weight Gain Trajectory
Interventions: THRIVE 2.0; Behavioral
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 1 Day and older
Enrollment: 148 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Pulmonary Arterial Hypertension
Interventions: Beraprost Sodium Modified Release; Drug
Lead sponsor: Lung Biotechnology PBC; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 6
States / cities: Torrance, California • Naperville, Illinois • New York, New York + 3 more

Conditions: Improved VO2max and Cardiac Output in Response to Training
Interventions: High intensity interval training; Other
Lead sponsor: California State University, San Marcos; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: San Marcos, California

Conditions: Depression, Social Anxiety
Interventions: UTalk; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 13 Years to 18 Years
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Coral Gables, Florida

Conditions: Endometrial Neoplasms, Soft Tissue Sarcoma (STS), Breast Neoplasms
Interventions: AL58805, AL8326, Eribulin, Fulvestrant; Drug
Lead sponsor: Advenchen Pharmaceuticals, LLC.; Industry
Eligibility: 18 Years and older
Enrollment: 138 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Drug Abuse
Interventions: brief intervention (cognitive-behavioral therapy); Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 13 Years to 19 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Healthy
Interventions: nikkomycin Z; Drug
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years to 40 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Sleep Disturbance, Sleep, Depression, Suicide
Interventions: Sleep Feedback + Psychoeducation, Transdiagnostic Sleep and Circadian Intervention + Bright Light (TSC+), Triple Chronotherapy (TCT+); Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 25 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Hypertension, Essential (Primary) Hypertension
Interventions: Mindfulness in Motion; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: HIV Infections
Interventions: Not listed
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 13 Years to 24 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 14
States / cities: Los Angeles, California • San Francisco, California • Washington D.C., District of Columbia + 10 more

Conditions: Severe Acute Alcoholic Hepatitis
Interventions: ELAD, Standard of Care treatment; Biological · Other
Lead sponsor: Vital Therapies, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 21
States / cities: Little Rock, Arkansas • San Diego, California • Washington D.C., District of Columbia + 16 more

Conditions: Parkinson Disease, Deep Brain Stimulation
Interventions: Biphasic deep brain stimulation, Conventional deep brain stimulation, Theta burst deep brain stimulation, Multi frequency deep brain stimulation; Device
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Food Hypersensitivity, Milk Hypersensitivity
Interventions: Baked Milk, Non-baked Milk; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 4 Years to 10 Years
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Stress, Emotional, Stress, Psychological, Behavioral Symptoms
Interventions: Technology Based Distractions; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 2 Years to 18 Years
Enrollment: 291 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Psychiatric Hospitalization, Physical Inactivity, Depression, Anxiety, Sleep
Interventions: OT-led Exercise Group, Treatment as Usual - OT Groups; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Multimorbidity, Physical Deconditioning
Interventions: Motivational Interviewing Techniques, Physical Therapy Interventions, Education, Health Status Updates, Physical Therapy Consult; Behavioral · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 60 Years and older
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Patients With Drug-resistant Focal Epilepsy, SEEG as Part of Presurgical Evaluation
Interventions: Direct Electric Stimulation (DES); Other
Lead sponsor: Hospices Civils de Lyon; Other
Eligibility: 18 Years to 55 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Chiropractic Maintenance Care and Heart Rate Variability
Interventions: Chiropractic Maintenance Care; Other
Lead sponsor: Northeast College of Health Sciences; Other
Eligibility: 18 Years to 40 Years · Male only
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Seneca Falls, New York

Conditions: Depression, Physical Activity
Interventions: tDCS, Sham tDCS, Aerobic Exercise (AE); Other · Behavioral
Lead sponsor: Butler Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Diabetic Macular Edema, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
Interventions: aflibercept, High-dose aflibercept; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 660 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 84
States / cities: Phoenix, Arizona • Arcadia, California • Beverly Hills, California + 78 more

Conditions: Hazardous Drinking, Posttraumatic Stress Disorder
Interventions: Alcohol-PTSD-PFI (AP-PFI), Active Comparison Condition (C-PFI); Other
Lead sponsor: University of Houston; Other
Eligibility: 21 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Discoid Lupus Erythematosus
Interventions: Placebo, Daxdilimab; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 16
States / cities: North Little Rock, Arkansas • Beverly Hills, California • Fremont, California + 12 more

Conditions: Systemic Sclerosis
Interventions: Belimumab, Rituximab, Placebo Subcutaneous Injection, Placebo Infusion, MMF; Drug · Other
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 18 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer

A Novel Obesity Prevention Program for High-Risk Infants in Primary Care

Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH)

Effect of Ethnicity on Changes in VO2max and Cardiac Output in Response to Short-Term High Intensity Interval Training

Coping With Adolescent Peer Victimization and Reducing Anxious/Depressed Symptoms

A Study of AL58805 in Advanced, Metastatic GYN, STS or Breast Cancers

Brief Intervention for Drug Abusing Adolescents

Safety and PK of Nikkomycin Z in Healthy Subjects

Sleep and Circadian Interventions for College Students at High Risk of Suicide

Evaluating the Effects of a Mindfulness Intervention on Health Outcomes in Individuals With Hypertension

HIV Treatment-Readiness Measure (HTRM) Validation

To Assess Safety/Efficacy of ELAD in Subjects w/ Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure

Safety and Tolerability of Patterned Stimulation for DBS in the Home Setting

Study of Milk Allergy and Tolerance in Children

VR Usage in Non-Invasive Surgical Sub-Specialty Procedures

Impact of Exercise Groups on Patient Mental Health and Wellbeing in an Acute Psychiatric Inpatient Unit

Multicomponent Telerehabilitation to Engage Veterans in Effective Self-Management of Complex Health Conditions

Links Between Epileptic Activity, Sleep Disruption and Mental Content During Sleep

Relationship Between Chiropractic Care and Autonomic Nervous System Regulation

tDCS for Increasing Exercise Adherence in Depressed Individuals

Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease

PFI Hazardous Drinkers With Subclinical PTSD

Study of Daxdilimab (HZN-7734) in Participants With Moderate-to-Severe Primary Discoid Lupus Erythematosus

Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis